Di halaman ini
CSBR Champions Oncology, Inc. - Common Stock
NASDAQ · Life Sciences Tools & Services · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Sep 11, 2026
$4,94
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$4,59rendah 52m
$8,31tinggi 52m
Kapitalisasi Pasar (MRQ)
$69M
P/E
-61.8
EPS
$-0.08
Pendapatan
$59M
lencana Anda
Rentang 52M
$5–$8
Peringkat Analis
BUY
Target Harga
·
P/E
-61.8
ROE
-30.5%
Margin Laba Bersih
-1.9%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
CSBR Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$4.94
Kapitalisasi Pasar (MRQ)
$69M
P/E
-61.8
EPS
$-0.08
Pendapatan
$59M
ROE
-30.5%
Rentang 52M
$5–$8
CSBR Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 12 Agu 2015 | 1-for-12 | Terbalik |
Tentang Champions Oncology, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist.
TumorGrafts
Champions TumorGrafts maintain the microenvironment surrounding the tumor and have been shown to have high correlation to the patient’s tumor. Due to this close resemblance to the human tumor, TumorGrafts are highly predictive of treatment outcomes in patients. Studies have shown the mouse avatars predict clinical benefit in 80% of patients. Approximately 450 TumorGrafts have been established as of April 2014.
TumorGrafts are also being used as a pre-clinical research tool to improve clinical drug development. Compared to traditional xenograft models, TumorGrafts, have a greater degree of accuracy in predicting clinical effectiveness of oncology drugs and thus can decrease clinical risk for drug developers. Champions has formed partnerships with multiple drug developers, including Teva and Pfizer.
The process
When a cancer patient undergoes surgery or biopsy, a living sample of the tumor is obtained and implanted into the mouse, creating a mouse avatar. Once the TumorGraft has successfully grown, the tumor is then propagated in a second generation of mice and tested against a panel of cancer drugs and drug combinations to help identify more accurately which treatment regimen is likely to be most effective in a specific patient. In this way, various drugs are tested on a live sample of the actual patient's tumor, rather than on the patient. This reduces the likelihood of treatment with ineffective drugs and their associated side effects, and it increases the likelihood of finding a treatment that will work against the patient's tumor. For patients whose tumors have also undergone molecular testing, such as next-generation sequencing, the selection of potential drugs is further guided by any and all applicable results. In the event the cancer progresses or recurs, Champions also banks, or stores, each successful TumorGraft for potential future patient use.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
sektorHealthcare
industriLife Sciences Tools & Services
karyawan214
negaraUS
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$59M2018-04-30 → 2026-04-30
EPS$-0.082018-04-30 → 2026-04-30
Arus Kas Bebas$-5M2017-04-30 → 2026-04-30
Margin bersih-1.9%2019-04-30 → 2026-04-30
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | CSBR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -61.8rata-rata 5T ≈23.5 | ≈23.5 | · | · | |
| P/S (TTM) | 1.1rata-rata 5T ≈1.6 | ≈1.6 | 2.7 | Kurang nilai | |
| P/B (MRQ) | 17.7rata-rata 5T ≈7.7 | ≈7.7 | 1.8 | Terlalu mahal | |
| Harga / FCF (TTM) | -11.2rata-rata 5T ≈14.8 | ≈14.8 | · | · | |
| Harga / Arus Kas (TTM) | -12.4rata-rata 5T ≈3.4 | ≈3.4 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 19.0rata-rata 5T ≈19.7 | ≈19.7 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | CSBR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | -1.7%rata-rata 5T ≈-3.4% | ≈-3.4% | -108.0% | Tingkat teratas | |
| Margin EBITDA (TTM) | 0.55%rata-rata 5T ≈-0.32% | ≈-0.32% | -108.0% | Tingkat teratas | |
| Margin Sebelum Pajak (TTM) | -1.5%rata-rata 5T ≈-3.3% | ≈-3.3% | -100.0% | Tingkat teratas | |
| Margin Laba Bersih (TTM) | -1.9%rata-rata 5T ≈-3.4% | ≈-3.4% | -105.8% | Tingkat teratas | |
| ROA | -4.0%rata-rata 5T ≈-5.1% | ≈-5.1% | -26.0% | Tingkat teratas | |
| ROE | -30.5%rata-rata 5T ≈92.6% | ≈92.6% | -34.9% | Sejajar | |
| ROIC | -36.6%rata-rata 5T ≈72.5% | ≈72.5% | -38.6% | Sejajar |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | CSBR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 1.0rata-rata 5T ≈0.9 | ≈0.9 | 2.9 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 0.9rata-rata 5T ≈0.8 | ≈0.8 | 1.4 | Likuiditas rendah |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | CSBR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 4.4%rata-rata 5T ≈8.1% | ≈8.1% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 3.3%rata-rata 5T ≈8.5% | ≈8.5% | · | · | |
| Revenue CAGR 5Y (CAGR Pendapatan 5T) | 7.7% | · | · | · | |
| EPS CAGR 3Y (CAGR EPS 3T) | 102.1% | · | · | · | |
| Net Income CAGR 3Y (CAGR Laba Bersih 3T) | 104.7% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | CSBR | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 2.0rata-rata 5T ≈1.7 | ≈1.7 | 0.4 | Tingkat teratas | |
| Receivables Turnover (Perputaran Piutang) | 4.9rata-rata 5T ≈5.7 | ≈5.7 | 5.0 | Sejajar | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$277.7K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-7.2%
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 31 Maret 2027 | Sep 10, 2026 | $-0.03 | $-0.01 | -194.1% |
| 30 Sep. 2026 | $-0.03 | $-0.01 | -194.1% | |
| 30 Juni 2026 | $-0.05 | $-0.05 | 2.0% | |
| 31 Maret 2026 | $-0.02 | $0.09 | -121.8% | |
| 31 Des. 2025 | $0.02 | $0.01 | 96.1% | |
| 30 Sep. 2025 | $0.02 | $-0.01 | 296.1% | |
| 30 Juni 2025 | $-0.07 | $-0.20 | 65.7% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $59M | $57M | $50M | $54M | $49M | $41M | $32M | $3M | $20M | |
| Cost of Revenue | $31M | $28M | $29M | $30M | $24M | $21M | $17M | · | · | |
| R&D Expense | $9M | $7M | $10M | $12M | $9M | $7M | $6M | $5M | $4M | |
| SG&A Expense | $11M | $9M | $11M | $10M | $9M | $7M | $7M | $5M | $4M | |
| Operating Expenses | · | · | · | · | · | · | $34M | $27M | $22M | |
| Operating Income | $-1M | $5M | $-7M | $-5M | $607.0K | $366.0K | $-2M | $270.0K | $-1M | |
| Other Non-op | $211.0K | $73.0K | $48.0K | $-11.0K | $-24.0K | $71.0K | $-42.0K | $-39.0K | $-89.0K | |
| Pretax Income | $-929.0K | $5M | $-7M | $-5M | $583.0K | $437.0K | $-2M | $231.0K | $-1M | |
| Income Tax | $246.0K | $-75.0K | $-32.0K | $68.0K | $35.0K | $75.0K | $130.0K | $103.0K | $33.0K | |
| Net Income | $-1M | $5M | $-7M | $-5M | $548.0K | $362.0K | $-2M | $128.0K | $-1M | |
| EPS (Basic) | $-0.08 | $0.34 | $-0.54 | $-0.39 | $0.04 | $0.03 | $-0.18 | $0.01 | $-0.13 | |
| EPS (Diluted) | $-0.08 | $0.33 | $-0.54 | $-0.39 | $0.04 | $0.02 | $-0.18 | $0.01 | $-0.13 | |
| Shares (Basic) | 13,832,385 | 13,659,786 | 13,547,604 | 13,541,559 | 13,197,170 | 13,138,995 | 11,843,463 | 11,340,184 | 10,991,105 | |
| Shares (Diluted) | 13,832,385 | 14,266,781 | 13,547,604 | 13,541,559 | 14,159,799 | 14,573,561 | 11,843,463 | 14,096,117 | 10,991,105 | |
| EBITDA | $260.0K | $6M | $-6M | $-3M | $2M | $2M | $-978.0K | $876.0K | $-994.0K |
Neraca
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $10M | $3M | $10M | $9M | $5M | $8M | $3M | $856.0K | |
| Receivables | $13M | $11M | $10M | $8M | $10M | $7M | $5M | $4M | $4M | |
| Prepaid Expense | $1M | $1M | $1M | $1M | $1M | $957.0K | $385.0K | $308.0K | $287.0K | |
| Current Assets | $19M | $22M | $14M | $19M | $20M | $13M | $13M | $8M | $5M | |
| PP&E (Net) | · | · | · | · | $7M | $6M | $4M | $3M | $2M | |
| PP&E (Gross) | $16M | $16M | $16M | $16M | $13M | $10M | $7M | $5M | $4M | |
| Accum. Depreciation | $13M | $12M | $10M | $9M | $6M | $4M | $3M | $2M | $1M | |
| Goodwill | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $670.0K | $669.0K | |
| Other Non-current Assets | $212.0K | $196.0K | $185.0K | $15.0K | $15.0K | $15.0K | $128.0K | $128.0K | $116.0K | |
| Total Assets | $27M | $32M | $26M | $34M | $35M | $28M | $21M | $11M | $8M | |
| Accounts Payable | $7M | $4M | $6M | $5M | $3M | $2M | $3M | $3M | $2M | |
| Accrued Liabilities | $3M | $3M | $2M | $2M | $2M | $2M | $3M | $1M | $569.0K | |
| Current Liabilities | $20M | $24M | $22M | $22M | $17M | $11M | $12M | $8M | $7M | |
| Capital Leases | $3M | $5M | $6M | $7M | $8M | $9M | $3M | $0 | $17.0K | |
| Other Non-current Liabilities | $7.0K | $85.0K | $401.0K | $551.0K | $391.0K | $181.0K | $178.0K | $151.0K | $151.0K | |
| Total Liabilities | $23M | $29M | $28M | $30M | $26M | $20M | $16M | $9M | $8M | |
| Common Stock | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $12.0K | $11.0K | |
| Retained Earnings | $-81M | $-80M | $-85M | $-77M | $-72M | $-73M | $-73M | $-71M | $-71M | |
| Treasury Stock | $708.0K | $708.0K | $708.0K | $74.0K | $0 | · | · | $0 | $1M | |
| Stockholders' Equity | $4M | $4M | $-2M | $5M | $9M | $7M | $5M | $2M | $3.0K | |
| Liabilities + Equity | $27M | $32M | $26M | $34M | $35M | $28M | $21M | $11M | $8M | |
| Shares Outstanding | 13,886,826 | 13,897,503 | 13,714,099 | 13,558,650 | 13,522,441 | 13,414,066 | 12,726,728 | 11,619,538 | 11,003,228 |
Arus Kas
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $2M | $2M | $2M | $2M | $925.0K | $825.0K | $606.0K | $360.0K | |
| Stock-based Comp | $1M | $654.0K | $1M | $864.0K | $912.0K | $598.0K | $600.0K | $636.0K | $1M | |
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | · | |
| Other Non-cash | $-6M | $431.0K | $-2M | $6M | $4M | $-4M | $3M | $492.0K | $-1M | |
| Operating Cash Flow | $-4M | $7M | $-6M | $4M | $6M | $-2M | $3M | $2M | $-1M | |
| CapEx | $564.0K | $389.0K | $836.0K | $3M | $2M | $3M | $2M | $834.0K | $1M | |
| Investing Cash Flow | $-540.0K | $-389.0K | $-836.0K | $-3M | $-2M | $-3M | $-2M | $-834.0K | $-1M | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | · | $0 | $634.0K | $74.0K | $0 | · | · | · | · | |
| Net Stock Activity | · | $0 | $-634.0K | $-74.0K | · | · | · | · | $0 | |
| Financing Cash Flow | $99.0K | $170.0K | $-527.0K | $11.0K | $207.0K | $1M | $4M | $1M | $13.0K | |
| Net Change in Cash | $-5M | $7M | $-8M | $1M | $4M | $-4M | $5M | $2M | $-2M | |
| Taxes Paid | $242.0K | $43.0K | · | · | · | · | · | · | · | |
| Free Cash Flow | $-5M | $7M | $-7M | $1M | $4M | $-5M | $685.0K | $1M | $-2M |
Profitabilitas
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1.9% | 8.0% | -14.7% | -9.8% | 1.2% | 0.89% | · | 1.0% | · | |
| Net Margin | -2.0% | 8.3% | -14.5% | -9.9% | 1.1% | 0.88% | · | 0.47% | · | |
| Pretax Margin | -1.6% | 8.1% | -14.6% | -9.8% | 1.2% | 1.1% | · | 0.85% | · | |
| EBITDA Margin | 0.44% | 10.8% | -11.3% | -5.9% | 4.3% | 3.8% | · | 3.2% | · | |
| ROA | -4.0% | 16.1% | -24.1% | -15.3% | 1.7% | 1.5% | -12.5% | 1.3% | -18.6% | |
| ROE | -30.5% | 211.1% | 367.4% | -91.2% | 6.0% | 4.7% | -36.9% | 5.6% | -744.4% | |
| ROIC | -36.6% | 122.7% | 384.9% | -114.8% | 6.3% | 4.1% | -36.3% | 6.7% | -46165.5% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 0.9 | 0.6 | 0.9 | 1.1 | 1.1 | 1.1 | 1.0 | 0.7 | |
| Quick Ratio | 0.9 | 0.9 | 0.6 | 0.8 | 1.1 | 1.0 | 1.1 | 0.9 | 0.6 |
Efisiensi
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.0 | 1.9 | 1.7 | 1.5 | 1.6 | 1.7 | · | 2.8 | · | |
| Receivables Turnover | 4.9 | 5.5 | 5.8 | 6.3 | 6.0 | 7.0 | · | 6.5 | · |
Per Saham
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.28 | $0.27 | $-0.14 | $0.34 | $0.67 | $0.55 | $0.42 | $0.19 | $0.00 | |
| Revenue / Share | $4.30 | $3.99 | $3.70 | $3.98 | $3.47 | $2.82 | · | $1.92 | · | |
| Cash Flow / Share | $-0.32 | $0.52 | $-0.45 | $0.29 | $0.46 | $-0.12 | $0.25 | $0.13 | · | |
| Cash / Share | $0.35 | $0.71 | $0.19 | $0.75 | $0.67 | $0.35 | $0.65 | $0.28 | $0.08 | |
| EPS (TTM) | $-0.08 | $0.33 | $-0.54 | $-0.39 | $0.04 | $0.02 | $-0.18 | $0.01 | $-0.13 |
Tingkat Pertumbuhan
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.4% | 13.5% | -6.9% | 9.7% | 19.7% | 27.8% | · | · | · | |
| Revenue CAGR 3Y | 3.3% | 5.1% | 6.9% | 18.8% | · | · | · | · | · | |
| Revenue CAGR 5Y | 7.7% | 12.1% | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | 100.0% | · | · | · | · | |
| EPS CAGR 3Y | · | 102.1% | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | 51.4% | · | · | · | · | |
| Net Income CAGR 3Y | · | 104.7% | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $59M | $57M | $50M | $54M | $49M | $41M | $32M | $3M | $20M | |
| Net Income TTM | $-1M | $5M | $-7M | $-5M | $548.0K | $362.0K | $-2M | $128.0K | $-1M | |
| Market Cap | $83M | $99M | $66M | $67M | $104M | $144M | $98M | $106M | $48M | |
| P/E | -74.5 | 21.7 | -9.0 | -12.6 | 192.0 | 536.5 | -42.9 | 908.0 | -33.4 | |
| P/S | 1.4 | 1.7 | 1.3 | 1.2 | 2.1 | 3.5 | 3.1 | 36.4 | 2.4 | |
| P/B | 21.0 | 26.1 | -34.6 | 14.4 | 11.4 | 19.4 | 18.5 | 47.1 | 15918.0 | |
| P / Tangible Book | 23.0 | 28.7 | · | 15.5 | 11.9 | 20.3 | 20.6 | · | · | |
| P / Cash Flow | -18.5 | 13.3 | -10.7 | 16.8 | 16.0 | -85.6 | 33.8 | 56.7 | -39.0 | |
| P / FCF | -16.4 | 14.1 | -9.4 | 60.6 | 25.2 | -29.0 | 143.4 | 102.6 | -19.5 | |
| Earnings Yield | -1.3% | 4.6% | -11.1% | -7.9% | 0.52% | 0.19% | -2.3% | 0.11% | -3.0% |
Laporan Laba Rugi
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $15M | $14M | $17M | $15M | $14M | $12M | $17M | $13M | $14M | $14M | $12M | $12M | $13M | $13M | $13M | $14M | |
| Cost of Revenue | $8M | $7M | $9M | $7M | $8M | $7M | $7M | $7M | $7M | $7M | $8M | $7M | $8M | $7M | $8M | $7M | |
| R&D Expense | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| SG&A Expense | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Income | $-409.0K | $-522.0K | $-276.0K | $185.0K | $-527.0K | $-2M | $4M | $732.0K | $1M | $-272.0K | $-3M | $-2M | $-3M | $-3M | $-2M | $7.0K | |
| Other Non-op | $-6.0K | $27.0K | $39.0K | $70.0K | $75.0K | $42.0K | $19.0K | $7.0K | $5.0K | $81.0K | $58.0K | $-105.0K | $14.0K | $-20.0K | $36.0K | $-9.0K | |
| Pretax Income | $-415.0K | $-495.0K | $-237.0K | $255.0K | $-452.0K | $-2M | $5M | $739.0K | $1M | $-191.0K | $-3M | $-2M | $-3M | $-3M | $-2M | $-2.0K | |
| Income Tax | $11.0K | $172.0K | $42.0K | $18.0K | $14.0K | $-130.0K | $23.0K | $11.0K | $21.0K | $-82.0K | $11.0K | $11.0K | $28.0K | $20.0K | $17.0K | $14.0K | |
| Net Income | $-426.0K | $-728.0K | $-279.0K | $268.0K | $-466.0K | $-2M | $4M | $728.0K | $1M | $-109.0K | $-3M | $-2M | $-3M | $-3M | $-2M | $-16.0K | |
| EPS (Basic) | $-0.03 | $-0.05 | $-0.02 | $0.02 | $-0.03 | $-0.14 | $0.33 | $0.05 | $0.10 | $-0.01 | $-0.19 | $-0.15 | $-0.19 | $-0.19 | $-0.18 | $0.00 | |
| EPS (Diluted) | · | $-0.05 | $-0.02 | $0.02 | $-0.03 | $-0.12 | $0.31 | $0.05 | $0.09 | $-0.01 | $-0.19 | $-0.15 | $-0.19 | $-0.19 | $-0.18 | $0.00 | |
| Shares (Basic) | 13,897,535 | · | 13,886,797 | 13,791,913 | 13,788,414 | · | 13,700,627 | 13,593,766 | 13,593,766 | · | 13,593,758 | 13,497,061 | 13,506,782 | · | 13,558,642 | 13,528,643 | |
| Shares (Diluted) | · | · | 13,886,797 | 14,457,837 | 13,788,414 | · | 14,364,904 | 14,016,953 | 14,042,379 | · | 13,593,758 | 13,497,061 | 13,506,782 | · | 13,558,642 | 13,528,643 | |
| EBITDA | $-95.0K | · | $65.0K | $542.0K | $-169.0K | · | $5M | $1M | $2M | · | $-2M | $-1M | $-2M | · | $-2M | $567.0K |
Neraca
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $5M | $7M | $9M | $10M | $10M | $3M | $3M | $3M | $3M | $4M | $6M | $5M | $10M | $12M | $11M | |
| Receivables | $14M | $13M | $12M | $12M | $9M | $11M | $16M | $10M | $9M | $10M | $8M | $8M | $9M | $8M | $8M | $9M | |
| Prepaid Expense | $1M | $1M | $991.0K | $1M | $1M | $1M | $713.0K | $860.0K | $1M | $1M | $835.0K | $780.0K | $1M | $1M | $661.0K | $834.0K | |
| Current Assets | $19M | $19M | $20M | $21M | $21M | $22M | $20M | $14M | $13M | $14M | $13M | $14M | $15M | $19M | $20M | $21M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $8M | |
| PP&E (Gross) | $17M | $16M | $16M | $16M | $16M | $16M | $17M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $15M | $14M | |
| Accum. Depreciation | $13M | $13M | $12M | $12M | $12M | $12M | $12M | $11M | $11M | $10M | $10M | $9M | $9M | $9M | $7M | $7M | |
| Goodwill | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | $335.0K | |
| Other Non-current Assets | $201.0K | $212.0K | $196.0K | $196.0K | $196.0K | $196.0K | $185.0K | $185.0K | $185.0K | $185.0K | $185.0K | $185.0K | $184.0K | $15.0K | $15.0K | $15.0K | |
| Total Assets | $33M | $27M | $28M | $30M | $31M | $32M | $31M | $25M | $25M | $26M | $27M | $28M | $30M | $34M | $36M | $36M | |
| Accounts Payable | $6M | $7M | $6M | $6M | $5M | $4M | $5M | $5M | $5M | $6M | $5M | $5M | $6M | $5M | $4M | $5M | |
| Accrued Liabilities | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Current Liabilities | $19M | $20M | $21M | $22M | $23M | $24M | $20M | $19M | $19M | $22M | $22M | $21M | $20M | $22M | $21M | $19M | |
| Capital Leases | $10M | $3M | $3M | $4M | $4M | $5M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $7M | $8M | $8M | |
| Other Non-current Liabilities | $215.0K | $7.0K | $27.0K | $46.0K | $66.0K | $85.0K | $285.0K | $324.0K | $363.0K | $401.0K | $439.0K | $476.0K | $514.0K | $551.0K | $588.0K | $624.0K | |
| Total Liabilities | $29M | $23M | $24M | $26M | $27M | $29M | $25M | $25M | $25M | $28M | $29M | $28M | $28M | $30M | $29M | $27M | |
| Common Stock | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | |
| Retained Earnings | $-81M | $-81M | $-80M | $-80M | $-80M | $-80M | $-78M | $-83M | $-83M | $-85M | $-84M | $-82M | $-80M | $-77M | $-75M | $-72M | |
| Treasury Stock | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $708.0K | $676.0K | $74.0K | · | · | |
| Stockholders' Equity | $4M | $4M | $4M | $4M | $4M | $4M | $5M | $681.0K | $-332.0K | $-2M | $-2M | $93.0K | $2M | $5M | $7M | $9M | |
| Liabilities + Equity | $33M | $27M | $28M | $30M | $31M | $32M | $31M | $25M | $25M | $26M | $27M | $28M | $30M | $34M | $36M | $36M | |
| Shares Outstanding | 13,918,569 | 13,886,826 | 13,886,826 | 13,886,326 | 13,788,421 | 13,777,170 | 13,705,570 | 13,698,903 | 13,593,766 | 13,593,766 | 13,593,766 | 13,593,766 | 13,484,110 | 13,544,228 | 13,558,650 | 13,558,650 |
Arus Kas
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $314.0K | $344.0K | $341.0K | $357.0K | $358.0K | $354.0K | $398.0K | $399.0K | $449.0K | $490.0K | $481.0K | $484.0K | $445.0K | $437.0K | $575.0K | $560.0K | |
| Stock-based Comp | $766.0K | $357.0K | $423.0K | $249.0K | $208.0K | $131.0K | $256.0K | $9.0K | $258.0K | $263.0K | $379.0K | $53.0K | $423.0K | $208.0K | $331.0K | $119.0K | |
| Other Non-cash | $-1M | · | · | · | $470.0K | · | · | · | $-2M | · | · | · | $-2M | · | · | · | |
| Operating Cash Flow | $-492.0K | $-2M | $-1M | $-2M | $600.0K | $7M | $490.0K | $-283.0K | $311.0K | $-2M | $-919.0K | $589.0K | $-4M | $-692.0K | $2M | $3M | |
| CapEx | $55.0K | $239.0K | $37.0K | $242.0K | $46.0K | $253.0K | $42.0K | $94.0K | $0 | $-3.0K | $18.0K | $79.0K | $668.0K | $760.0K | $754.0K | $604.0K | |
| Investing Cash Flow | $-55.0K | $-238.0K | $-14.0K | $-242.0K | $-46.0K | $-253.0K | $-42.0K | $-94.0K | $0 | $3.0K | $-18.0K | $-79.0K | $-668.0K | $-760.0K | $-754.0K | $-604.0K | |
| Stock Repurchased | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $32.0K | $602.0K | $74.0K | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $0 | · | · | · | $-602.0K | · | · | · | |
| Financing Cash Flow | $33.0K | $-19.0K | $-36.0K | $168.0K | $-14.0K | $-32.0K | $0 | $239.0K | $-37.0K | $-37.0K | $-108.0K | $134.0K | $-590.0K | $-75.0K | $0 | $86.0K | |
| Net Change in Cash | $-514.0K | $-2M | $-1M | $-2M | $540.0K | $7M | $448.0K | $-138.0K | $274.0K | $-2M | $-1M | $644.0K | $-5M | $-2M | $819.0K | $3M | |
| Free Cash Flow | $-547.0K | · | · | · | $554.0K | · | · | · | $311.0K | · | · | · | $-5M | · | · | · |
Profitabilitas
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2.7% | · | -1.7% | 1.2% | -3.8% | · | 26.4% | 5.4% | 9.4% | · | -21.4% | -16.9% | -20.3% | · | -19.2% | 0.05% | |
| Net Margin | -2.8% | · | -1.7% | 1.8% | -3.1% | · | 26.4% | 5.4% | 9.3% | · | -21.1% | -17.9% | -20.4% | · | -19.1% | -0.11% | |
| Pretax Margin | -2.7% | · | -1.4% | 1.7% | -3.2% | · | 26.5% | 5.5% | 9.5% | · | -21.0% | -17.8% | -20.2% | · | -19.0% | -0.01% | |
| EBITDA Margin | -0.62% | · | 0.39% | 3.6% | -1.2% | · | 28.7% | 8.4% | 12.6% | · | -17.4% | -12.7% | -16.8% | · | -14.7% | 4.0% | |
| ROA | -1.3% | · | -0.94% | 0.97% | -1.6% | · | 15.7% | 2.7% | 4.8% | · | -8.0% | -6.4% | -8.0% | · | -7.0% | -0.05% | |
| ROE | -11.5% | · | -5.7% | 11.1% | -27.5% | · | 263.6% | 188.1% | 167.2% | · | -101.1% | -44.7% | -47.1% | · | -29.9% | -0.19% | |
| ROIC | -10.8% | · | -7.6% | 4.1% | -15.5% | · | 81.8% | 105.9% | -394.0% | · | 125.8% | -2113.4% | -135.6% | · | -35.0% | 0.61% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | · | 1.0 | 1.0 | 0.9 | · | 1.0 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 1.0 | 1.1 | |
| Quick Ratio | 1.0 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | 0.7 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.9 | 1.1 |
Efisiensi
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | |
| Receivables Turnover | 1.3 | · | 1.2 | 1.4 | 1.5 | · | 1.4 | 1.5 | 1.6 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.7 |
Per Saham
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.28 | · | $0.31 | $0.30 | $0.25 | · | $0.40 | $0.05 | $-0.02 | · | $-0.15 | $0.01 | $0.14 | · | $0.52 | $0.68 | |
| Revenue / Share | · | · | $1.19 | $1.04 | $1.01 | · | $1.19 | $0.96 | $1.00 | · | $0.88 | $0.86 | $0.93 | · | $0.94 | $1.06 | |
| Cash Flow / Share | · | · | · | · | $0.04 | · | · | · | $0.02 | · | · | · | $-0.30 | · | · | · | |
| Cash / Share | $0.31 | · | $0.51 | $0.61 | $0.75 | · | $0.23 | $0.20 | $0.21 | · | $0.33 | $0.41 | $0.36 | · | $0.86 | $0.80 | |
| EPS (TTM) | $-0.08 | · | $-0.15 | $0.18 | $0.21 | · | $0.44 | $-0.06 | $-0.26 | · | $-0.72 | $-0.71 | $-0.56 | · | $-0.22 | $0.01 |
Valuasi (TTM)
| Metrik | Tren | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $61M | · | $58M | $58M | $57M | · | $59M | $54M | $52M | · | $49M | $50M | $53M | · | $54M | $54M | |
| Net Income TTM | $-1M | · | $-2M | $2M | $3M | · | $6M | $-598.0K | $-3M | · | $-10M | $-10M | $-8M | · | $-3M | $108.0K | |
| Market Cap | $75M | · | $102M | $95M | $87M | · | $151M | $54M | $65M | · | $79M | $74M | $88M | · | $56M | $94M | |
| P/E | -67.0 | · | -48.7 | 37.9 | 30.1 | · | 25.0 | -65.2 | -18.4 | · | -8.1 | -7.7 | -11.6 | · | -18.7 | 694.0 | |
| P/S | 1.2 | · | 1.8 | 1.6 | 1.5 | · | 2.6 | 1.0 | 1.3 | · | 1.6 | 1.5 | 1.7 | · | 1.0 | 1.7 | |
| P/B | 19.2 | · | 23.7 | 22.7 | 24.8 | · | 27.5 | 78.7 | -196.1 | · | -38.4 | 798.1 | 46.1 | · | 7.9 | 10.3 | |
| P / Tangible Book | 21.0 | · | 25.7 | 24.7 | 27.5 | · | 29.3 | 154.8 | · | · | · | · | 55.9 | · | 8.3 | 10.6 | |
| P / Cash Flow | -151.6 | · | · | · | 145.2 | · | · | · | 209.4 | · | · | · | -22.0 | · | · | · | |
| Earnings Yield | -1.5% | · | -2.1% | 2.6% | 3.3% | · | 4.0% | -1.5% | -5.4% | · | -12.4% | -13.0% | -8.6% | · | -5.3% | 0.14% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|---|
| Pendapatan | $59M | $57M | $50M | $54M | $49M |
| Margin Operasi % | -1.9% | 8.0% | -14.7% | -9.8% | 1.2% |
| Laba Bersih | $-1M | $5M | $-7M | $-5M | $548.0K |
| EPS Dilusian | $-0.08 | $0.33 | $-0.54 | $-0.39 | $0.04 |
| Metrik | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|---|
| Rasio Lancar | 1.0 | 0.9 | 0.6 | 0.9 | 1.1 |
| Rasio Cepat | 0.9 | 0.9 | 0.6 | 0.8 | 1.1 |
| Metrik | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-5M | $7M | $-7M | $1M | $4M |
Pemilik institusional (13F) 29 pengaju · $38.4M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
29
Nilai yang dipegang
$38.4M
Posisi baru
4
Posisi yang keluar
2
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 4 (0 vs Kuartal sebelumnya) | 2 (-3 vs Kuartal sebelumnya) | 5 (0 vs Kuartal sebelumnya) | 7 (0 vs Kuartal sebelumnya) | +134K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| BATTERY MANAGEMENT CORP. | $14.917.506 | 2.421.673 | 38,86% | Saham |
| NEA Management Company, LLC | $10.556.515 | 1.713.720 | 27,50% | Saham |
| VANGUARD GROUP INC | $2.312.121 | 334.605 | 6,02% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.856.334 | 301.353 | 4,84% | Saham |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $1.821.253 | 295.658 | 4,74% | Saham |
| MORGAN STANLEY | $1.450.064 | 235.400 | 3,78% | Saham |
| BANK OF AMERICA CORP /DE/ | $1.318.597 | 214.058 | 3,43% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $856.480 | 139.039 | 2,23% | Saham |
| BlackRock, Inc. | $799.864 | 129.848 | 2,08% | Saham |
| Mink Brook Asset Management LLC | $685.842 | 111.338 | 1,79% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $470.118 | 76.300 | 1,22% | Saham |
| HighTower Advisors, LLC | $258.110 | 41.901 | 0,67% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $204.752 | 33.239 | 0,53% | Saham |
| NORTHERN TRUST CORP | $171.926 | 27.910 | 0,45% | Saham |
| STATE STREET CORP | $161.410 | 26.203 | 0,42% | Saham |
| Bank of New York Mellon Corp | $133.142 | 21.614 | 0,35% | Saham |
| CITADEL ADVISORS LLC | $112.697 | 18.295 | 0,29% | Saham |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $112.241 | 18.221 | 0,29% | Saham |
| Mesirow Financial Investment Management, Inc. | $97.328 | 15.800 | 0,25% | Saham |
| MERCER GLOBAL ADVISORS INC /ADV | $78.694 | 12.775 | 0,20% | Saham |
| Vanguard Global Advisers, LLC | $12.893 | 2.093 | 0,03% | Saham |
| ACADIAN ASSET MANAGEMENT LLC | $125 | 20.523 | 0,00% | Saham |
| BARCLAYS PLC | $80 | 13 | 0,00% | Saham |
| Cambridge Investment Research Advisors, Inc. | $75 | 12.252 | 0,00% | Saham |
| JPMORGAN CHASE & CO | $71 | 11 | 0,00% | Saham |
| Cassaday & Co Wealth Management LLC | $62 | 10 | 0,00% | Saham |
| SBI Securities Co., Ltd. | $25 | 4 | 0,00% | Saham |
| FMR LLC | $5 | 1 | 0,00% | Saham |
| Capital Advisors, Ltd. LLC | $0 | 48 | 0,00% | Saham |
Aktivis & pemilik 5%+ 9 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| New Enterprise Associates 14, L.P., NEA Partners 14, L.P., NEA 14 GP, LTD, Forest Baskett, Anthony A. Florence, Jr., Patrick J. Kerins, Mohamad Makhzoumi, Scott D. Sandell ×2 pengajuan | 6 Mei 2024 | · | Pengajuan awal | · | SEC |
| Norman H. Pessin, Brian Pessin ×2 pengajuan | 8 Agu 2017 | · | Pengajuan awal | Investasi pasif | SEC |
| PAR Investment Partners, L.P., PAR Group, L.P., PAR Capital Management, Inc., Arthur G. Epker, III ×4 pengajuan | 28 Okt. 2016 | · | Pengajuan awal | · | SEC |
| Joel Ackerman ×2 pengajuan | 23 Maret 2015 | · | Pengajuan awal | Investasi pasif | SEC |
| Ronnie Morris ×2 pengajuan | 23 Maret 2015 | · | Pengajuan awal | Investasi pasif | SEC |
| Battery Ventures IX, L.P., Battery Investment Partners IX, LLC, Battery Partners IX, LLC, Battery Management Corp., Scott R. Tobin, Thomas J. Crotty, Richard D. Frisbie, Kenneth P Lawler, R. David Tabors, Roger H. Lee, Neeraj Agrawal, Michael M. Brown, Jesse Feldman ×4 pengajuan | 16 Maret 2015 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan | 29 Mei 2007 | · | Pengajuan awal | · | SEC |
| Manuel Hidalgo. | 18 Jan. 2007 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan | 11 Jan. 2007 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 18 orang dalam · 7 pejabat · 11 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Robert Lawrence Brainin | CEO | 16 Juli 2025 A | · | 0 | 0 | $0 |
| Ronnie Morris | CEO | 17 Maret 2023 P | 858.878 | 0 | 0 | $0 |
| CHAMPIONS SPORTS INC | Chairman, President and CEO | 11 Okt. 2004 P | 9.548.000 | 0 | 0 | $0 |
| Mark Schonau | Accting PEO and CFO | 21 Juli 2010 A | 8.526 | 0 | 0 | $0 |
| Brady Davis | President | 9 Okt. 2023 A | · | 0 | 0 | $0 |
| Douglas D Burkett | President | 3 Okt. 2008 P | · | 0 | 0 | $0 |
| David Barry Miller | Vice President, Finance | 21 Juli 2016 D | · | 0 | 0 | $0 |
| Philip P. Breitfeld | Direktur | 5 Nov. 2025 A | 5.717 | 0 | 0 | $0 |
| Daniel Newman Mendelson | Direktur | 5 Nov. 2025 A | 198.625 | 0 | 0 | $0 |
| David Sidransky | Direktur | 5 Nov. 2025 A | 767.043 | 0 | 0 | $0 |
| Joel Ackerman | Direktur | 5 Nov. 2025 A | 1.056.539 | 0 | 0 | $0 |
| Scott R. Tobin | Direktur | 5 Nov. 2025 A | 30.000 | 0 | 0 | $0 |
| Abba David Poliakoff | Direktur | 19 Jan. 2021 M | 81.274 | 0 | 0 | $0 |
| Arthur G Epker III | Direktur | 13 Okt. 2014 A | · | 0 | 0 | $0 |
| Ana Stancic | Direktur | 14 Juli 2011 A | · | 0 | 0 | $0 |
| Michael M. Brown | Pemilik 10% | 28 Jan. 2013 A | 16.031.040 | 0 | 0 | $0 |
| James Martell | · | 6 Jan. 2012 G | 1.784.828 | 0 | 0 | $0 |
| Durwood Settles | · | 15 Jan. 2007 A | · | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 3 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
CSBR Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 7 analis
BELI
2 28,6%
Beli Kuat
4 57,1%
Beli
1 14,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| CSBR | $83M | -74.5 | 4.4% | -2.0% | -30.5% | · |
| NAUT | $247M | -4.1 | · | · | -34.9% | · |
| QTRX | $297M | -2.5 | 1.1% | -77.1% | -36.4% | 46.8% |
| CDXS | $147M | -3.3 | 18.6% | -62.5% | -82.8% | · |
| SEER | · | -1.4 | 17.0% | · | · | · |
| MXCT | $166M | -3.7 | -14.5% | -135.1% | -24.6% | 81.2% |
| HYFT | · | · | · | -89.7% | -78.9% | 58.8% |
| CIRC | · | · | · | · | · | · |
| RPID | · | -2.8 | 19.7% | -140.3% | -107.4% | · |
| HBIO | $30M | -0.5 | -8.1% | -65.5% | -384.8% | 57.7% |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | · |
Sinyal Perdagangan Sinyal beli/jual terbaru dengan harga masuk dan rasio risiko/imbalan
Tidak ada sinyal terbuka saat ini — tidak ada kartu yang terisi, dan itu jujur.
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Sep 11, 2026